Advertisement

Heterogeneity of Benzodiazepine Receptors

  • Kelvin W. Gee
  • Frederick J. Ehlert
  • William R. Roeske
  • Henry I. Yamamura

Abstract

Evidence has accumulated from almost a decade of study of neurotransmitter and putative neurotransmitter receptors to support the conclusion that most neurotransmitters interact with a heterogeneous population of receptors. The existence of receptor subtypes for various neurotransmitters provides a means by which the functional capabilities of a neurotransmitter may be extended.

Keywords

Gaba Receptor Conformational State Photoaffinity Label Competition Curve Cortical Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dale, H. H., 1914, J. Pharmacol. Exp. Ther. 6:147–190.Google Scholar
  2. 2.
    Seeman, P., 1980, Pharmacol. Rev. 32:229–313.PubMedGoogle Scholar
  3. 3.
    Ahlquist, R. P., 1948, Am. J. Physiol. 153:586–600.PubMedGoogle Scholar
  4. 4.
    Langer, S. Z., 1974, Biochem. Pharmacol. 23:1793–1800.PubMedCrossRefGoogle Scholar
  5. 5.
    Berthelsen, S., and Pettinger, W. A., 1977, Life Sci. 21:595–606.PubMedCrossRefGoogle Scholar
  6. 6.
    Chang, K. J., and Cuatrecasas, P., 1981, Fed. Proc. 40:2729–2734.PubMedGoogle Scholar
  7. 7.
    Gilbert, P. E., and Martin, W. R., 1976, J. Pharmacol. Exp. Ther. 198:66–82.PubMedGoogle Scholar
  8. 8.
    Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., and Gilbert, P. E., 1976, J. Pharmacol. Exp. Ther. 197:517–532.PubMedGoogle Scholar
  9. 9.
    Ash, A. S. V., and Schild, H. O., 1966, Br. J. Pharmacol. 27:427–439.Google Scholar
  10. 10.
    Squires, R. F., and Braestrup, C., 1977, Nature 266:732–734.PubMedCrossRefGoogle Scholar
  11. 11.
    Mohler, H., and Okada, T., 1977, Science 198:849–851.PubMedCrossRefGoogle Scholar
  12. 12.
    Young, W. S., III, and Kuhar, M. J., 1980, J. Pharmacol. Exp. Ther. 212:337–346.PubMedGoogle Scholar
  13. 13.
    Mao, C. C., Guidotti, A., and Costa, E., 1975, Naunyn Schmiedebergs Arch. Pharmacol. 289:369–378.PubMedCrossRefGoogle Scholar
  14. 14.
    Polc, P., Mohler, H., and Haefely, W., 1974, Naunyn Schmiedebergs Arch. Pharmacol. 284:319–337.PubMedCrossRefGoogle Scholar
  15. 15.
    Suria, A., and Costa, E., 1975, Brain Res. 87:102–106.PubMedCrossRefGoogle Scholar
  16. 16.
    Costa, E., Guidotti, A., Mao, C. C., and Suria, A., 1975, Life Sci. 17:167–186.PubMedCrossRefGoogle Scholar
  17. 17.
    Tallman, J. F., Thomas, J. W., and Gallager, D. W., 1978, Nature 274:383–385.PubMedCrossRefGoogle Scholar
  18. 18.
    Martin, I. L., and Candy, J. M., 1978, Neuropharmacology 17:993–998.PubMedCrossRefGoogle Scholar
  19. 19.
    Wastek, G., Speth, R., Reisine, T., and Yamamura, H. I., 1978, Eur. J. Pharmacol. 50:445–447.PubMedCrossRefGoogle Scholar
  20. 20.
    Karobath, M., and Sperk, G., 1979, Proc. Natl. Acad. Sci. U.S.A. 76:1004–1008.PubMedCrossRefGoogle Scholar
  21. 21.
    Unnerstall, J., Kuhar, M., Niehoff, D., and Palacios, J., 1981, J. Pharmacol. Exp. Ther. 218:797–804.PubMedGoogle Scholar
  22. 22.
    Briley, M. S., and Langer, S. Z., 1978, Eur. J. Pharmacol. 52:129–132.PubMedCrossRefGoogle Scholar
  23. 23.
    Maggi, A., Satinover, J., Oberdorfer, M., Mann, E., and Enna, S. J., 1980, Brain Res. Bull. 5(Suppl. 2):167–171.CrossRefGoogle Scholar
  24. 24.
    Reisine, T. D., Overstreet, D., Gale, K., Rossor, M., Iversen, L. L., and Yamamura, H. I., 1980, Brain Res. 199:79–88.PubMedCrossRefGoogle Scholar
  25. 25.
    Costa, T., Rodbard, D., and Pert, C., 1979, Nature 277:315–316.PubMedCrossRefGoogle Scholar
  26. 26.
    Tallman, J. F., Paul, S. M., Skolnick, P., and Gallager, D. W., 1980, Science 207:274–281.PubMedCrossRefGoogle Scholar
  27. 27.
    Olsen, R. W., 1982, Annu. Rev. Pharmacol. Toxicol. 22:245–277.PubMedCrossRefGoogle Scholar
  28. 28.
    Speth, R. C., Guidotti, A., and Yamamura, H.I., 1981, Nervous System and Behavioral Dis orders (G. Palmer ed.), Academic Press, New York, pp. 243–283.Google Scholar
  29. 29.
    Speth, R. C., Wastek, G. J., Johnson, P. C., and Yamamura, H. I., 1978, Life Sci. 22:859–866.PubMedCrossRefGoogle Scholar
  30. 30.
    Squires, R. F., Benson, P. I., ßraestrup, C., Coupet, J., Kiepner, C. A., Myers, V., and Beer, B., 1979, Pharmacol. Biochem. Behav. 10:825–830.PubMedCrossRefGoogle Scholar
  31. 31.
    Lippa, A. S., Coupet, J., Greenblatt, E. N., Kiepner, C. A., and Beer, B., 1979, Pharmacol. Biochem. Behav. 11:99–106.PubMedCrossRefGoogle Scholar
  32. 32.
    Kiepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C., and Beer, B., 1979, Pharmacol. Biochem. Behav. 11:457–462.CrossRefGoogle Scholar
  33. 33.
    Yamamura, H. I., Mimaki, T., Yamamura, S. H., Horst, W. D., Morelli, M., Bautz, G., and O’Brien, R. A., 1982, Eur. J. Pharmacol. 77:351–354.PubMedCrossRefGoogle Scholar
  34. 34.
    Young, W. S. III, Niehoff, D., Kuhar, M. J., Beer, B., and Lippa, A. S., 1981, J. Pharmacol. Exp. Ther. (E. Usdin, P. Skolnick, J. F. Tallman, D. Greenblatt, and S. M. Paul, eds.) 216:425–430.Google Scholar
  35. 35.
    Braestrup, C., Schmiechen, R., Nielsen, M., and Petersen, E. N., 1982, Pharmacology of Benzodiaze pines (S. M. Paul, eds.), Macmillian, London (in press).Google Scholar
  36. 36.
    Petersen, E. N., and Buus Lassen, J., 1981, Psychopharmacology 75:236–239.PubMedCrossRefGoogle Scholar
  37. 37.
    Regan, J., Roeske, W. R., Malick, J., Yamamura, S. H., and Yamamura, H. I., 1981, Mol. Pharmacol. 20:477–483.PubMedGoogle Scholar
  38. 38.
    Niehoff, D. L., Marshall, R. D., Horst, W. D., O’Brien, R. A., Palacios, J. M., and Kuhar, M. J., 1982, J. Pharmacol. Exp. Ther. 221:670–675.PubMedGoogle Scholar
  39. 39.
    Gee, K. W., Ehlert, F. J., and Yamamura, H. I., 1983, J. Pharmacol. Exp. Ther. 225:132–137.PubMedGoogle Scholar
  40. 40.
    Papez, J. W., 1937, Arch. Neurol. Psychiatry 38:725–743.CrossRefGoogle Scholar
  41. 41.
    Braestrup, C., Nielsen, M., and Olsen, C., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:2288–2292.PubMedCrossRefGoogle Scholar
  42. 42.
    Ehlert, F. J., Roeske, W. R., and Yamamura, H. I., 1981, Life Sci. 29:235–248.PubMedCrossRefGoogle Scholar
  43. 43.
    Nielsen, M., and Braestrup, C., 1981, Nature 286:606–607.CrossRefGoogle Scholar
  44. 44.
    Mitchell, R., and Martin, I. L., 1980, Eur. J. Pharmacol. 68:513–514.PubMedCrossRefGoogle Scholar
  45. 45.
    Oakley, N. R., and Jones, B. J., 1980, Eur. J. Pharmacol. 68:381–382.PubMedCrossRefGoogle Scholar
  46. 46.
    Tenen, S. S., and Hirsch, J. D., 1980, Nature 288:609–610.PubMedCrossRefGoogle Scholar
  47. 47.
    Cowen, P. J., Green, A. R., Nutt, D. J., and Martin, I. L., 1981, Nature 290:54–55.PubMedCrossRefGoogle Scholar
  48. 48.
    Nielsen, M., Schou, H., and Braestrup, C., 1981, J. Neurochem. 36:276–285.PubMedCrossRefGoogle Scholar
  49. 49.
    Braestrup, C., and Nielsen, M., 1980, Trends Neurosci. 3:301–302.Google Scholar
  50. 50.
    Hirsch, J. D., 1982, Pharmacol. Biochem. Behav. 16:245–248.PubMedCrossRefGoogle Scholar
  51. 51.
    Hirsch, J. D., Kochman, R. L., and Sumner, P. R., 1982, Mol. Pharmacol. 21:618–628.PubMedGoogle Scholar
  52. 52.
    Gee, K. W., and Yamamura, H. I., 1982, Eur. J. Pharmacol. 82:239–241.PubMedCrossRefGoogle Scholar
  53. 53.
    Johnson, R. W., and Yamamura, H. I., 1979, Life Sci. 25:1613–1620.PubMedCrossRefGoogle Scholar
  54. 54.
    Mohler, H., 1982, Eur. J. Pharmacol. 80:435–436.PubMedCrossRefGoogle Scholar
  55. 55.
    Thomas, J. W., and Tallman, J. F., 1981, J. Biol. Chem. 256:9838–9842.PubMedGoogle Scholar
  56. 56.
    Braestrup, C., and Nielsen, M., 1981, Nature 294:472–474.PubMedCrossRefGoogle Scholar
  57. 57.
    Squires, R., Kiepner, C., and Benson, E., 1980, Receptors for Neurotransmitters and Peptide Hormones (G. Pepeu, M. Kuhar, and S. Enna, eds.), Raven Press, New York, pp. 285–293.Google Scholar
  58. 58.
    Yousufi, M., Thomas, J., and Tallman, J., 1979, Life Sci. 25:463–469.CrossRefGoogle Scholar
  59. 59.
    Lang, B., Barnard, E., Change, L., and Dolly, D., 1979, FEBS Lett. 104:149–153.PubMedCrossRefGoogle Scholar
  60. 60.
    Gavish, M., Chang, R., and Snyder, S., 1979, Life Sci. 25:783–789.PubMedCrossRefGoogle Scholar
  61. 61.
    Asano, T., and Ogasawara, N., 1980, Life Sci. 26:607–613.PubMedCrossRefGoogle Scholar
  62. 62.
    Seighart, W., and Karobath, M., 1980, Nature 286:285–287.CrossRefGoogle Scholar
  63. 63.
    Mohler, H., Battersby, M. K., and Richards, J. G., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:1666–1670.PubMedCrossRefGoogle Scholar
  64. 64.
    Tallman, J. F., Mallorga, P., Thomas, J. W., and Gallager, D. W., 1981, GABA and Benzo-diazepine Receptors (E. Costa, G. DiChiara, and G. L. Gessa, eds.), Raven Press, New York, pp. 9–18.Google Scholar
  65. 65.
    Braestrup, C., Nielsen, M., Skovbjerg, H., and Gredal, O., 1981, GABA and Benzodiazepine Receptors ,(E. Costa, G. DiChiara, and G. L. Gessa, eds.), Raven press, New York, pp. 147–156.Google Scholar
  66. 66.
    Lo, M. M. S., Strittmatter, S. M., and Snyder, S. H., 1982, Proc. Natl. Acad. Sci. U.S.A. 79:680–684.PubMedCrossRefGoogle Scholar
  67. 67.
    Speth, R. C., Wastek, G. J., and Yamamura, H. I., 1979, Life Sci. 24:351–358.PubMedCrossRefGoogle Scholar
  68. 68.
    Gee, K. W., Morelli, M., and Yamamura, H. I., 1982, Biochem. Biophys. Res. Commun. 105:1532–1537.PubMedCrossRefGoogle Scholar
  69. 69.
    Gee, K. W., Ehlert, F. J., and Yamamura, H. I., 1982, Biochem. Biophys. Res. Commun. 106:1134–1140.PubMedCrossRefGoogle Scholar
  70. 70.
    Ehlert, F. J., Roeske, W. R., Gee, K. W., and Yamamura, H. I., 1983, Biochem. Pharmacol. 32:2375–2383.PubMedCrossRefGoogle Scholar
  71. 71.
    Braestrup, C., Nielsen, M., Krosgaard-Larsen, P., and Falch, E., 1979, Nature 280:331–333.PubMedCrossRefGoogle Scholar
  72. 72.
    Karobath, M., and Sperck, G., 1979, Proc. Natl. Acad. Sci. U.S.A. 76:1004–1008.PubMedCrossRefGoogle Scholar
  73. 73.
    Birdsall, N. J. M., Burgen, A. S. V., and Hulme, E. C., 1977, Cholinergic Mechanisms and Psychopharmacology (D. J. Jenden, ed.), Plenum Press, New York, pp. 25–33.Google Scholar
  74. 74.
    Ehlert, F. J., Roeske, W. R., and Yamamura, H. I., 1983, Handbook of Psychopharmacology ,(L. Iversen, S. Iversen, and S. H. Snyder, eds.), Plenum Press, New York 17:241–284.Google Scholar
  75. 75.
    Mohler, H., Burkard, W. P., Keller, H. H., Richards, J. G., and Haefely, W., 1981, J. Neurochem. 37:714–722.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Kelvin W. Gee
    • 1
    • 2
  • Frederick J. Ehlert
    • 1
    • 2
  • William R. Roeske
    • 1
    • 2
  • Henry I. Yamamura
    • 1
    • 2
  1. 1.Departments of Pharmacology, Internal Medicine, Biochemistry, PsychiatryUniversity of Arizona Health Sciences CenterTucsonUSA
  2. 2.Arizona Research LaboratoriesUniversity of Arizona Health Sciences CenterTucsonUSA

Personalised recommendations